Molecular Immunology

Special Issues

Following special issues within this section are currently open for submissions:

• Molecular and Immunological Approaches in Ophthalmology: Inflammatory Disorders (Deadline: 10 December 2022)
• Tumor Immune Microenvironment and Immunotherapy: Novel Insights and Future Perspectives in HCC (Deadline: 15 December 2022)
• Molecular Immunology of Solid Tumors 2.0 (Deadline: 15 December 2022)
• Immune Modulation of Macrophages (Deadline: 15 December 2022)
• Frontiers in Psoriasis (PsO) and Psoriatic Arthritis (PSA) (Deadline: 15 December 2022)
• Innate Immune Cell Effector Responses (Deadline: 15 December 2022)
• Tackle Lung Cancer by Means of Novel Immunotherapeutic Strategies (Deadline: 15 December 2022)
• Mesenchymal Stem Cells: Immunobiology and Role in Immunomodulation and Tissue Regeneration 2.0 (Deadline: 20 December 2022)
• Allosteric Regulation of the Hormone and Growth Factor Receptors (Deadline: 25 December 2022)
• The Twist and Turn of Lipids in Human Diseases (Deadline: 28 December 2022)
• Multiple Sclerosis at the Crossroads of Autoimmunity and Neurodegeneration (Deadline: 29 December 2022)
• Immunological Investigations in Hematology 2.0 (Deadline: 30 December 2022)
• Molecular Pathogenesis and Treatment of T-cell Lymphoma (Deadline: 30 December 2022)
• Effects of Chronic Inflammation on Brain Ageing and Sensory Decline (Deadline: 30 December 2022)
• Amniotic Fluid and Placental Membranes as Sources of Stem Cells 2.0 (Deadline: 30 December 2022)
• Neonatal Immunology (Deadline: 30 December 2022)
• Interleukin 22 (Deadline: 30 December 2022)
• State-of-the-Art Molecular Immunology in Chile (Deadline: 30 December 2022)
• Molecular Mechanisms of Allergy and Skin Diseases (Deadline: 30 December 2022)
• Molecular Mechanisms of Pathogenesis, Prevention, and Therapy of COVID-19: Summarizing the Results of 2022 (Deadline: 31 December 2022)
• The Research of Neutrophil 2.0 (Deadline: 31 December 2022)
• Fish Mucosal Physiology and Immunology 2.0 (Deadline: 31 December 2022)
• Oral Medicine and Immunity (Deadline: 31 December 2022)
• Immunologic and Non-immunologic Mechanisms Leading to Airway Remodeling in Asthma (Deadline: 31 December 2022)
• Psoriatic Arthritis: Pathogenesis and Targeted Therapies (Deadline: 31 December 2022)
• Interaction between Gut Microbiome and Mucosal Immunity in the Gastrointestinal Disorders (Deadline: 31 December 2022)
• New Insights into Molecular Innate Immunity (Deadline: 31 December 2022)
• Immune Functions of Astrocytes (Deadline: 31 December 2022)
• Role of NF-kappaB Pathway in Inflammation and Infection (Deadline: 31 December 2022)
• Anticancer Drug Development and Cancer Immunotherapy (Deadline: 31 December 2022)
• Proteomics for the Study of Inflammatory Diseases (Deadline: 31 December 2022)
• The Pathogenesis of Rheumatoid Arthritis—Breakthroughs in Molecular Mechanisms 2.0 (Deadline: 31 December 2022)
• Updates in Cell and Molecular Mechanisms of Autoimmune Diseases (Deadline: 31 December 2022)
• Mechanisms and Means of Immune Modulation in Innate and Adaptive Immunity (Deadline: 31 December 2022)
• Abiogenic Metal Cations: Friends or Foes in Host Immunity and Health (Deadline: 31 December 2022)
• Molecular Mechanisms of Cellular and Tissue Stress, Canonical and Non-classical Forms of Pro-inflammatory Processes in Health and Disease (Deadline: 31 December 2022)
• Advances in Targeted Immunotherapy in Cancers (Deadline: 31 December 2022)
• Fc Receptors 2.0 (Deadline: 31 December 2022)
• The Role of Progesterone in the Feto-Maternal Immunological Relationship (Deadline: 31 December 2022)
• Biomaterials, Neuroimmunology and Stem Cells for Repair Strategies in the Central Nervous System (Deadline: 31 December 2022)
• Viral Condensates and Virus Interference with Host Membraneless Organelles (Deadline: 31 December 2022)
• Key Players in Connective Tissue Diseases: The Immune System and Beyond (Deadline: 31 December 2022)
• IL-36 Family Cytokines in Physiological and Pathophysiological Inflammation (Deadline: 31 December 2022)
• Proteomics and Gene Regulation of Infectious Disease (Deadline: 31 December 2022)
• New Therapeutic Approaches in Chronic Inflammatory Diseases and Reproductive System Cancer (Deadline: 31 December 2022)
• Phenotypic and Functional Heterogeneity of Cells of the Monocytes/Macrophage Lineage (Deadline: 15 January 2023)
• Antibodies in Autoimmune Diseases (Deadline: 15 January 2023)
• Innate Immunity in Autoimmune Diseases (Deadline: 20 January 2023)
• Immune Factors, Immune Cells and Inflammatory Diseases (Deadline: 20 January 2023)
• Molecular Genetics and Pathogenesis of Atopic Dermatitis and Psoriasis (Deadline: 30 January 2023)
• Inflammation and the Musculoskeletal System (Deadline: 30 January 2023)
• Thyroid Autoimmunity and Autoimmune Hypothyroidism (Deadline: 31 January 2023)
• Molecular Pathogenesis and Therapies for Autoimmune Blistering Diseases (Deadline: 31 January 2023)
• Monitoring Immune Responses in Renal Autoimmune and Autoinflammatory Diseases (Deadline: 31 January 2023)
• OSM/OSMR and Interleukin 6 Family Cytokines in Physiological and Pathological Condition 2.0 (Deadline: 31 January 2023)
• New Trends in Inflammation Management (Deadline: 31 January 2023)
• Osteoimmunology in Rheumatic Diseases (Deadline: 31 January 2023)
• Mesenchymal Stromal Cells’ Involvement in Human Diseases and Their Treatment (Deadline: 31 January 2023)
• Environmental Determinants and Their Impact on Human Reproduction and Reproductive Immunology (Deadline: 31 January 2023)
• Cancer Immunotherapy Using Checkpoint Inhibitors: Future Directions 3.0 (Deadline: 31 January 2023)
• Immune Response in Atopic Dermatitis (Deadline: 31 January 2023)
• Molecular Mechanisms Underlying Pituitary Pathogenesis (Deadline: 31 January 2023)
• State-of-the-Art Molecular Immunology in Italy (Deadline: 31 January 2023)
• NF-κB and Disease 3.0 (Deadline: 31 January 2023)
• Neutrophil Extracellular Traps (NETs) in Immunity and Diseases (Deadline: 31 January 2023)
• State-of-the-Art Molecular Immunology in France (Deadline: 31 January 2023)
• The Role of Mast Cells and Their Inflammatory Mediators in Immunity (Deadline: 31 January 2023)
• Inflammatory Bowel Disease: Immune Function, Tissue Fibrosis and Current Therapies (Deadline: 31 January 2023)
• Inflammation, Inflammatory Diseases, and Inflammasomes (Deadline: 31 January 2023)
• Reproductive Immunology and Pregnancy 3.0 (Deadline: 31 January 2023)
• Chronic Inflammatory Lung Diseases: Molecular Pathology (Deadline: 31 January 2023)
• Neuroinflammation in the Pathogenesis of Alzheimer's Disease and Related Dementias (Deadline: 31 January 2023)
• Sleep Apnea and Systemic Inflammation (Deadline: 31 January 2023)
• The Pathway of Antigen Processing and Presentation (Deadline: 31 January 2023)
• Skin Inflammation and Allergy (Deadline: 31 January 2023)
• Molecular Mechanisms of Endothelial Dysfunction 2.0 (Deadline: 31 January 2023)
• Immune Checkpoint Inhibitors and Immune Checkpoint Resistance (Deadline: 31 January 2023)
• Targeted Cancer Therapy Using Monoclonal Antibodies (Deadline: 31 January 2023)
• Advances in Immunotherapeutic Approaches to Type 1 Diabetes 2.0 (Deadline: 31 January 2023)
• Lipid Molecules in Inflammation and Chronic Diseases 2.0 (Deadline: 31 January 2023)
• Allograft Rejection: Emerging Molecular Mechanisms and Biomarkers (Deadline: 31 January 2023)
• Immunopathogenesis and Novel Therapeutics Strategies of Systemic Lupus Erythematosus (Deadline: 31 January 2023)
• Immunometabolism and Immunologic Mechanisms in Allergy Diseases (Deadline: 31 January 2023)
• Macrophages in Respiratory Diseases (Deadline: 31 January 2023)
• Immunopathology of Atherosclerosis and Related Diseases: Focus on Molecular Biology 3.0 (Deadline: 10 February 2023)
• Radiation-Induced Immune Modulation: Implications in Combination Immunotherapy (Deadline: 15 February 2023)
• Autoimmune Diseases: A Swing Dance of the Immune Cells (Deadline: 15 February 2023)
• NK Cell Subsets in Health and Disease: New Developments (Deadline: 15 February 2023)
• Pattern Recognition Receptors in Gastrointestinal Inflammation and Cancer (Deadline: 25 February 2023)
• Effects of Exercise Release Mediated Myokines on Immune System (Deadline: 25 February 2023)
• Challenges and Future Trends of Hepatocellular Carcinoma Immunotherapy (Deadline: 28 February 2023)
• Neuroinflammation: The Pathogenic Mechanism of Neurological Disorders 2.0 (Deadline: 28 February 2023)
• Cell Signaling and Immune Targets in Cancer (Deadline: 28 February 2023)
• Molecular and Cellular Basis of Allergies and Allergic Asthma (Deadline: 28 February 2023)
• Causes, Molecular Research, and Treatment in Skin Inflammation (Deadline: 28 February 2023)
• Insights in Multiple Sclerosis (MS) and Neuroimmunology (Deadline: 28 February 2023)
• Advanced Therapy Medicinal Products as Potential Therapeutic Strategy against COVID-19 and Immune-Related Disorders (Deadline: 28 February 2023)
• Mechanisms of Innate Immune Activation and Regulation in Health and Disease (Volume 2) (Deadline: 28 February 2023)
• Centenarians—a Model to Study the Molecular Basis of Lifespan and Healthspan 2.0 (Deadline: 28 February 2023)
• Advances in Experimental and Clinical Aspects of Allergies and Autoimmunity (Deadline: 28 February 2023)
• Immunity and Inflammation in Health and Disease: Insights into Sex-Based Mechanisms and Their Modifiers (Deadline: 28 February 2023)
• Immune Regulations in Transplant (Deadline: 28 February 2023)
• Stress, Immunity, and Tissue Microenvironment 2.0 (Deadline: 28 February 2023)
• Advances in Single Domain-Based Antibodies (Deadline: 28 February 2023)
• Recent Advances in Immunotheragnostics: From Molecular Basis to Targeted Pharmaceutical Design 2.0 (Deadline: 28 February 2023)
• Novel Molecular Research in Skin Inflammation (Deadline: 28 February 2023)
• Non-coding RNAs in Pathogens and Associated Diseases (Deadline: 28 February 2023)
• Mechanisms of Vascular Calcification 2.0 (Deadline: 28 February 2023)
• Interleukin in Allergic and Immune-Mediated Diseases (Deadline: 28 February 2023)
• Inflammatory Signaling Pathways Involved in Gastrointestinal Diseases (Deadline: 28 February 2023)
• Roles of the Immune System in Neuropathic Pain (Deadline: 28 February 2023)
• Chronic Rhinosinusitis: Aetiology, Immunology and Treatment (Deadline: 28 February 2023)
• New Roles for Old Friends: Involvement of the Innate Immune System in Tumor Progression (Deadline: 28 February 2023)
• Beta Thymosins: The Role in Immunity, Organ Regeneration, Development and Aging (Deadline: 28 February 2023)
• Latest Review Papers in Molecular Immunology 2023 (Deadline: 28 February 2023)
• Endometrium and Pregnancy Immune Tolerance (Deadline: 28 February 2023)
• Lymphatic Vascular Growth and Remodeling in Pathophysiology-New Findings and Avenues (Deadline: 10 March 2023)
• Skin, Autoimmunity and Inflammation (Deadline: 15 March 2023)
• The Role of Toll-Like Receptors (TLR) in Infection and Inflammation (Deadline: 15 March 2023)
• Molecular Pathology and Genetics of Autoimmune Diseases (Deadline: 20 March 2023)
• Pathogenesis, Immunity and Therapy of Systemic Sclerosis: Molecular Aspects (Deadline: 25 March 2023)
• Arthritis and Inflammatory Cytokine (Deadline: 29 March 2023)
• New Targeted Therapeutic Strategies of Multiple Myeloma (Deadline: 31 March 2023)
• Immune Modulation and the Microbiome (Deadline: 31 March 2023)
• Pediatric Rheumatic Diseases: Molecular Basis and Therapies (Deadline: 31 March 2023)
• Inflammatory Diseases: From Molecular Basis to Therapy (Deadline: 31 March 2023)
• Tolerogenic Cell-Based Therapy: Where We Stand 2.0? (Deadline: 31 March 2023)
• Molecular and Biochemical Aspects in Burns (Deadline: 31 March 2023)
• Molecular Advances of Viral Immunology and Vaccine against Viruses (Deadline: 31 March 2023)
• Cytokine and Its Downstream Signaling in Pregnancy and Fetal Development (Deadline: 31 March 2023)
• Molecular Mechanisms of Skin Autoimmunity and Hypersensitivity (Deadline: 31 March 2023)
• The Role of Nucleic Acids in Normal and Aberrant Immunity (Deadline: 31 March 2023)
• Mast Cells in Human Health and Diseases 2.0 (Deadline: 31 March 2023)
• Editorial Board Members’ Collection Series: "Autoimmune" (Deadline: 31 March 2023)
• State-of-the-Art Molecular Immunology in Canada (Deadline: 31 March 2023)
• Fish Immunology 3.0 (Deadline: 31 March 2023)
• The Immunology of Hepatitis B Infection (Deadline: 31 March 2023)
• Mast Cells in Immunity and Diseases (Deadline: 31 March 2023)
• Immunophenotyping in Autoimmune Diseases and Cancer 3.0 (Deadline: 31 March 2023)
• Advances of Immuno-Oncology for Thoracic Cancers (Deadline: 31 March 2023)
• Pathogenesis and Management of Mastocytosis (Deadline: 31 March 2023)
• Advances in Endothelial Cell Biology 3.0 (Deadline: 31 March 2023)
• Monoclonal Antibodies & Immunotherapy to Treat Cancer: Current Knowledge, Emerging Targets and Future Perspectives (Deadline: 31 March 2023)
• Inflammatory Diseases, Dysbiosis and Infections (Deadline: 31 March 2023)
• Macrophages, Immunity and Inflammation in Health and Disease (Deadline: 31 March 2023)
• New Insight into B Cell Biology (Deadline: 31 March 2023)
• The Future of Cancer Immunotherapy: Microenvironment-Targeting Combinations (Deadline: 31 March 2023)
• Targeting Stromal Cell Signaling within the Tumor Microenvironment (Deadline: 31 March 2023)
• Pathophysiology and Therapy of Bladder Function Disorders and Cystitis (Deadline: 31 March 2023)
• The Road to Tolerance: Molecular Biomarkers for Prediction and Diagnosis of Post-transplant Complications in Liver Transplantation (Deadline: 31 March 2023)
• Biological Interfaces in Gastrointestinal Cancer 3.0 (Deadline: 31 March 2023)
• The Interaction between Host Immunity and Hepatitis B Virus Infection 2022 (Deadline: 10 April 2023)
• Targeting TRP Channels for Pain, Itch and Inflammation Relief (Deadline: 15 April 2023)
• Macrophage Polarization: Learning to Manage It 2.0 (Deadline: 15 April 2023)
• The Role of Inflammation in Diabetic Retinopathy (Deadline: 30 April 2023)
• Infection and the Kidney 2.0 (Deadline: 30 April 2023)
• Molecular Targets for Biological Therapies of Severe Asthma II (Deadline: 30 April 2023)
• Thrombo-Inflammatory Extracellular Vesicles 2.0 (Deadline: 30 April 2023)
• T Cells in Cancer Immunotherapy (Deadline: 30 April 2023)
• Molecular Biology and Immunological Advances in Hematological Malignancies (Deadline: 30 April 2023)
• Reproductive Immunology: New Insights into Physiology and Pathophysiology of Pregnancy (Deadline: 30 April 2023)
• Spondyloarthritis: Molecular Mechanisms and Novel Therapies (Deadline: 30 April 2023)
• Therapeutic Antibody Development: What Are We Learning along the Way? 2.0 (Deadline: 30 April 2023)
• Metabolic Inflammation: From Molecular Mechanisms to Drug Targeting (Deadline: 30 April 2023)
• Infectious Agents and Inflammatory Diseases (Deadline: 30 April 2023)
• Novel Immunomodulatory Approaches for Lung Fibrosis (Deadline: 1 May 2023)
• Pro-inflammatory and Anti-inflammatory Interleukins in Various Diseases (Deadline: 10 May 2023)
• Molecular Medicine in Asthma and Allergic Diseases (Deadline: 15 May 2023)
• The Immune Checkpoint HLA-G 2.0 (Deadline: 20 May 2023)
• Interplay between Tumor Metabolism and Immunology (Deadline: 25 May 2023)
• Regulatory T Cells in Human Disease and in Transplantation (Deadline: 30 May 2023)
• Neutrophil in Cell Biology and Diseases 2.0 (Deadline: 31 May 2023)
• Molecular Advances in Cell-Based Immunotherapy (Deadline: 31 May 2023)
• Cellular and Molecular Immune Research on Renal Transplantation (Deadline: 31 May 2023)
• Inflammation in Health and Disease: New Insights and Therapeutic Avenues 3.0 (Deadline: 31 May 2023)
• Metabolic Regulation in Innate Immune Cells in Health and Disease (Deadline: 31 May 2023)
• Immune Response to Cancer: From Tumor Onset to Therapeutic Approach 2.0 (Deadline: 31 May 2023)
• Cancer Immunotherapy: Recent Progress (Deadline: 31 May 2023)
• Molecular Immunology in Hematological Disorders 2.0 (Deadline: 31 May 2023)
• Immuno-Metabolism of Sepsis (Deadline: 31 May 2023)
• Alcohol and Inflammation (Deadline: 31 May 2023)
• Targeting CAR T-cell Therapy: Molecular Research & Its Future Implication (Deadline: 31 May 2023)
• Molecular Immunology of the Male Reproductive System (Deadline: 31 May 2023)
• State-of-the-Art Molecular Immunology in Japan (Deadline: 31 May 2023)
• Molecular Mechanisms of Treating Psoriasis (Deadline: 31 May 2023)
• Periodontal Disease, Association with Systemic Conditions and Periodontal Pathogens (Deadline: 1 June 2023)
• Mucosal Administration of Vaccines (Deadline: 15 June 2023)
• Cellular and Viral Immunology of HIV-1 Infection: An Update (Deadline: 20 June 2023)
• Signaling Mechanisms in Orchestrating Host Immune Responses: An Update (Deadline: 20 June 2023)
• Inflammatory Tissue Response—How Nature Fights Back (Deadline: 30 June 2023)
• Biomarkers of Autoimmune Chronic Spontaneous Urticaria (Deadline: 30 June 2023)
• The Role of Immunity and Inflammation in Pulmonary Fibrosis (Deadline: 30 June 2023)
• The Role of Neutrophils in Inflammatory Diseases (Deadline: 30 June 2023)
• Immune Mechanisms and Biomarkers in Systemic Lupus Erythematosus (Deadline: 30 June 2023)
• Complement System Entry Suspense: A Hero or Villain in Rare and Genetic Diseases (Deadline: 30 June 2023)
• Mesenchymal Stem Cells and Dendritic Cells in Immune Diseases and Cancers (Deadline: 30 June 2023)
• Advance in Immunotherapy of Melanoma and Skin Cancers (Deadline: 31 July 2023)
• Advance Research in Immuno-Oncology Drug Development (Deadline: 31 July 2023)

Topical Collections

Following topical collections within this section are currently open for submissions:

• Feature Papers in Molecular Immunology
• Oral Inflammation—Environment, Molecules, and Cells in Oral Physiology and Pathology
• State-of-the-Art Molecular Immunology in Germany
• State-of-the-Art Molecular Immunology in USA
• The Adaptive Immunity in COVID-19